Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF V600E Mutation in Involuting Nevus in a Patient Treated With Vemurafenib.

JAMA dermatology - 1 Jun 2017

Millán-Cayetano José Francisco, Fernández-Canedo Inés, Blázquez-Sánchez Nuria, Fúnez-Liébana Rafael, de Troya-Martín Magdalena

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cell Line, Tumor
Share to DNA, Neoplasm
Share to Fatal Outcome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Share to Vemurafenib

Source

Identifiers

PMID: 28249088
DOI: 10.1001/jamadermatol.2016.6091

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF V600E Mutation in Involuting Nevus in a Patient Treated With Vemurafenib.PMID 28249088Read ↗

N-Ras mutation in vemurafenib-associated expanding melanocytic nevus.Semantic proximity Read ↗

BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinib.Semantic proximity Read ↗

BRAF Mutations Are Common Somatic Events in Melanocytic Nevi11Tables 2 and 3 can be found at http://www.blackwellpublishing.com/products/journals/suppmat/jid/jid22225/jid22225sm.htmSemantic proximity Read ↗

High incidence of naevi-associated BRAF wild-type melanoma and dysplastic naevi under treatment with the class I BRAF inhibitor vemurafenib.Semantic proximity Read ↗

Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.Semantic proximity Read ↗

Rapidly metastasizing malignant melanoma characterized by a rare BRAF mutation not responding to vemurafenib.Semantic proximity Read ↗

Vemurafenib-associated keratoses with genetic heterogeneity of RAS.Semantic proximity Read ↗

Vemurafenib therapy for stage IV melanoma with V600G-mutation.Semantic proximity Read ↗

Nonmalignant cutaneous findings associated with vemurafenib.Semantic proximity Read ↗

Frequent BRAF V600E Mutations in Metanephric Stromal TumorSemantic proximity Read ↗

A rare BRAF V600E mutation detected by next-generation sequencing in a superficial spreading melanoma: case report and potential diagnostic implications.Semantic proximity Read ↗

Histopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.